A pilot study investigating the effect of Caralluma fimbriata extract on the risk factors of metabolic syndrome in overweight and obese subjects: a randomised controlled clinical trial.

Katie Canteri

Research output: Contribution to journalArticlepeer-review

19 Citations (Scopus)
Original languageEnglish
JournalComplementary Therapies in Medicine
Publication statusPublished - 2013
Externally publishedYes

Cite this